|
|
|
|
| LEADER |
00763nam a2200253 a 4500 |
| 001 |
adlib96000001 |
| 003 |
ViArRB |
| 005 |
20151026132155.0 |
| 008 |
960221s1955 dcuabcdjdbkoqu001 0deng d |
| 020 |
|
|
|
| 022 |
|
|
|
| 040 |
|
|
|a Adlib
|
| 082 |
|
|
|a 615.015.2
|
| 245 |
|
|
|a WHO drug information
|
| 250 |
|
|
|
| 260 |
|
|
|a Geneva
|b World Health Organisation
|c 2004
|
| 300 |
|
|
|a 109p.
|
| 500 |
|
|
|a Vol.18, No.1
|
| 100 |
|
|
|
| 700 |
|
|
|
| 942 |
|
|
|c BK
|6 _
|
| 653 |
|
|
|a Quality assurance issues
|a Drugs- information
|a Pharmacology
|a Drugs--Physiological effect
|a Drugs--Testing
|a Malaria medica
|a Medicine
|a Drug therapy
|
| 999 |
|
|
|c 43166
|d 43166
|
| 952 |
|
|
|0 0
|1 0
|4 0
|6 6150152_WHO181
|7 0
|9 55286
|a UL
|b UL
|d 2010-06-16
|o 615.015.2 WHO.18(1)
|p G0008613
|r 2010-06-16
|w 2010-06-16
|y BK
|